Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
The Korean Journal of Physiology and Pharmacology ; : 237-243, 2013.
Artículo en Inglés | WPRIM | ID: wpr-727724

RESUMEN

B13 is a ceramide analogue and apoptosis inducer with potent cytotoxic activity. A series of arylpropyl sulfonamide analogues of B13 were evaluated for their cytotoxicity using MTT assays in prostate cancer PC-3 and leukemia HL-60 cell lines. Some compounds (4, 9, 13, 14, 15, and 20) showed stronger activities than B13 in both tumor cell lines, and compound (15) gave the most potent activity with IC50 values of 29.2 and 20.7 microM, for PC-3and HL-60 cells, respectively. Three-dimensional quantitative structure-activity relationship (3D-QSAR) analysis was performed to build highly reliable and predictive CoMSIA models with cross-validated q2 values of 0.816 and 0.702, respectively. Our results suggest that long alkyl chains and a 1R, 2R configuration of the propyl group are important for the cytotoxic activities of arylpropyl sulfonamides. Moreover, the introduction of small hydrophobic groups in the phenyl ring and sulfonamide group could increase biological activity.


Asunto(s)
Humanos , Apoptosis , Línea Celular Tumoral , Células HL-60 , Concentración 50 Inhibidora , Leucemia , Neoplasias de la Próstata , Relación Estructura-Actividad Cuantitativa , Sulfonamidas
2.
The Korean Journal of Physiology and Pharmacology ; : 441-447, 2010.
Artículo en Inglés | WPRIM | ID: wpr-727385

RESUMEN

B13, a ceramide analogue, is a ceramidase inhibitor and induces apoptosis to give potent anticancer activity. A series of thiourea B13 analogues was evaluated for their in vitro cytotoxic activities against human renal cancer Caki-2 and leukemic cancer HL-60 in the MTT assay. Some compounds (12, 15, and 16) showed stronger cytotoxicity than B13 and C6-ceramide against both tumor cell lines, and compound (12) gave the most potent activity with IC50 values of 36 and 9 microM, respectively. Molecular modeling of thiourea B13 analogues was carried out by comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA). We obtained highly reliable and predictive CoMSIA models with cross-validated q2 values of 0.707 and 0.753 and CoMSIA contour maps to show the structural requirements for potent activity. These data suggest that the amide group of B13 could be replaced by thiourea, that the stereochemistry of 1,3-propandiol may not be essential for activity and that long alkyl chains increase cytotoxicity.


Asunto(s)
Humanos , Apoptosis , Línea Celular Tumoral , Ceramidasas , Ceramidas , Células HL-60 , Concentración 50 Inhibidora , Neoplasias Renales , Modelos Moleculares , Relación Estructura-Actividad , Tiourea
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA